In order to verify that breast cancer cells indeed develop ER stress response when treated with BN108 or TAIII, we have examined phosphorylation of the translation initiation factor eIF2α, considered to be a hallmark of ER stress response. The gene discussed is EIF2A; the disease is breast cancer.